Emv Capital (EMVC) RNS Announcements

Add to Alert list
Date Time Source Announcement
14 Feb 2020 03:12 PM
RNS
Holding(s) in Company
12 Feb 2020 11:07 AM
RNS
PDS equity issue and related party transaction
11 Feb 2020 02:24 PM
RNS
PDS Biotechnology proposed offering
15 Jan 2020 07:00 AM
RNS
Board Change
18 Dec 2019 11:24 AM
RNS
Holding(s) in Company
17 Dec 2019 03:04 PM
RNS
Holding(s) in Company
13 Dec 2019 01:21 PM
RNS
Board Changes
21 Nov 2019 07:00 AM
RNS
Glycotest receives 2nd $3m tranche of $10m finance
17 Oct 2019 02:14 PM
RNS
Holding(s) in Company
14 Oct 2019 07:00 AM
RNS
Appointment to the Board
03 Oct 2019 01:44 PM
RNS
PDS collaborates with Merck in Phase 2 studies
01 Oct 2019 02:10 PM
RNS
PDS prioritise PDS0101 in high risk HPV to Phase 2
19 Sep 2019 01:24 PM
RNS
PDS - positive data for immunotherapy treatment
19 Sep 2019 11:00 AM
RNS
Interim Results for six months ended 30 June 2019
01 Aug 2019 01:44 PM
RNS
PDS second quarter 2019 financial results
31 Jul 2019 08:41 AM
RNS
PDS Biotechnology Corp liquidity funding program
09 Jul 2019 02:58 PM
RNS
Holding(s) in Company
08 Jul 2019 04:04 PM
RNS
Holding(s) in Company
18 Jun 2019 02:27 PM
RNS
Result of Annual General Meeting
31 May 2019 07:00 AM
RNS
Positive new data demonstrates NEATstiks potential
24 May 2019 09:50 AM
RNS
Notice of AGM and Annual Report & Accounts
22 May 2019 07:00 AM
RNS
Full Year Results for the year ended 31 Dec 2018
16 May 2019 03:07 PM
RNS
PDS Biotechnology journal publication
25 Apr 2019 07:00 AM
RNS
Resignation of CEO
22 Mar 2019 04:42 PM
RNS
Sale of Wanda and Vortex
19 Mar 2019 07:00 AM
RNS
PDS merger with Edge Therapeutics update
18 Mar 2019 02:09 PM
RNS
PDS completes merger with Edge Therapeutics
18 Mar 2019 02:07 PM
RNS
Orderly wind up of Wanda and Vortex
14 Mar 2019 07:00 AM
RNS
Share Price Movement
04 Mar 2019 11:45 AM
RNS
Results of General Meeting
01 Mar 2019 11:15 AM
RNS
Update on upcoming General Meeting
27 Feb 2019 04:40 PM
RNS
Second Price Monitoring Extn
27 Feb 2019 04:35 PM
RNS
Price Monitoring Extension
27 Feb 2019 02:05 PM
RNS
Second Price Monitoring Extn
27 Feb 2019 02:00 PM
RNS
Price Monitoring Extension
25 Feb 2019 12:54 PM
RNS
Holding(s) in Company
21 Feb 2019 04:35 PM
RNS
Holding(s) in Company
20 Feb 2019 10:51 AM
RNS
Holding(s) in Company
19 Feb 2019 02:06 PM
RNS
Second Price Monitoring Extn
19 Feb 2019 02:00 PM
RNS
Price Monitoring Extension
18 Feb 2019 04:54 PM
RNS
Holding(s) in Company
18 Feb 2019 11:06 AM
RNS
Second Price Monitoring Extn
18 Feb 2019 11:00 AM
RNS
Price Monitoring Extension
15 Feb 2019 12:00 PM
RNS
Conclusion of Strategic Review
14 Feb 2019 12:07 PM
RNS
Glycotest Receives First $3m Tranche from Fosun
15 Jan 2019 11:08 AM
RNS
Termination of Formal Sales Process
20 Dec 2018 04:41 PM
RNS
Second Price Monitoring Extn
20 Dec 2018 04:36 PM
RNS
Price Monitoring Extension
20 Dec 2018 07:00 AM
RNS
Update on Strategic Review
30 Nov 2018 03:46 PM
RNS
Form 8 (OPD) - NetScientific (Offeree)

EMV Capital is a London venture capital company that invests in early-stage, IP-rich, technology and life sciences companies in the UK and internationally.

It is listed on AIM under the ticker EMVC.

EMVC share price launched at 1,620p in 2013.

UK 100

Latest directors dealings